Andrew D.C. LaFrence - Nov 23, 2021 Form 4/A - Amendment Insider Report for Vyant Bio, Inc. (VYNT)

Role: Chief Financial Officer
Signature: /s/ Andrew LaFrence
Stock symbol: VYNT
Transactions as of: Nov 23, 2021
Transactions value $: $9,998
Form type: 4/A - Amendment
Date filed: 12/29/2021, 03:30 PM
Date Of Original Report: Nov 24, 2021
Previous filing: May 21, 2021
Next filing: Mar 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNT	Common Stock, $0.0001 par value	Purchase	$10K	+5K	+17.07%	$2.00	34.3K	Nov 23, 2021	Direct	F1
holding	VYNT	Common Stock, $0.0001 par value						29.8K	Nov 23, 2021	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9995 to $2.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2	Includes 3,000 shares previously held directly by the Reporting Person which were transferred to this joint trust account.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9995 to $2.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Includes 3,000 shares previously held directly by the Reporting Person which were transferred to this joint trust account.

Remarks:

This Form 4 is being filed to amend the amount of securities beneficially owned following the reported transaction as reported in the Form 4 filed on November 24, 2021.